Abstract
Polycystic ovary syndrome (PCOS) is one of the most common endocrine diseases with an uncertain pathology and the most frequent incretory disorder in women of reproductive age, often leading to female infertility. Evidence has shown that genetic factors may contribute to the etiology of PCOS. Contradictory results have been reported concerning the association between PCOS and the CYP11A1 gene promoter −528 bp pentanucleotide (tttta)n repeat polymorphism. In order to get an overall understanding of the association between the CYP11A1 gene promoter −528 bp pentanucleotide (tttta)n repeat polymorphism and PCOS, case–control studies regarding this association were extracted from MEDLINE, Ovid EMBASE and PubMed and pooled for meta-analysis. In dichotomous allelic analyses with 1,236 PCOS patients and 1,306 control subjects, the odds ratios (ORs) were very close to 1. In dichotomous genotypic analyses with 1,063 PCOS patients and 1,176 control subjects, the (tttta)4 genotype may increase the risk of PCOS in a recessive model with OR 1.44, 95 % confidence interval (CI) 1.12–1.85, and the (tttta)6 genotype may decrease the risk of PCOS in a dominant model with OR 0.76, 95 % CI 0.61–0.93. In continuous analyses with 1,085 PCOS patients and 1,216 control subjects, the Mean Difference (MD) was −0.07 with a 95 % CI −0.18 to 0.05, showing no difference between PCOS and control groups. No publication bias was found in either dichotomous or continuous analyses. Taken together, there may be an association between CYP11A1 promoter pentanucleotide repeat polymorphism and PCOS. Further research is needed to strictly confirm our findings.
Similar content being viewed by others
References
Teede H, Deeks A, Moran L (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8:41
Eshre R (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19
Glueck C et al (2009) Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population. Metabolism 58:714–721
Moran LJ et al (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 16(4):347–363
Dokras A (2012) Mood and anxiety disorders in women with PCOS. Steroids 77(4):338–341
Franks S, Gharani N, McCarthy M (2001) Candidate genes in polycystic ovary syndrome. Hum Reprod Update 7(4):405–410
Urbanek M et al (1999) Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 96(15):8573–8578
Zheng W et al (2004) Population-based case-control study of CYP11A gene polymorphism and breast cancer risk. Cancer Epidemiol Biomark Prev 13(5):709–714
Gharani N et al (1997) Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 6(3):397–402
Hochkirchen T (2007) A handbook of statistical analysis using R. J R Stat Soc Ser A Stat Soc 170((Part 2)):506–507
Schwarzer G, Schwarzer MG (2007) The meta package. R package version 0.8-2
Higgins J et al (2003) Measuring inconsistency in meta-analyses. Br Med J 327(7414):557–560
DerSimonian R, Laird N (1986) Metaanalysis in clinical-trials. Control Clin Trials 7(3):177–188
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748
Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315(7109):629–634
Peters JL et al (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA 295(6):676–680
Rucker G, Schwarzer G, Carpenter J (2008) Arcsine test for publication bias in meta-analyses with binary outcomes. Stat Med 27(5):746–763
Diamanti-Kandarakis E et al (2000) Microsatellite polymorphism (tttta)(n) at -528 base pairs of gene CYP11alpha influences hyperandrogenemia in patients with polycystic ovary syndrome. Fertil Steril 73(4):735–741
Perez MS et al (2008) Polymorphism in CYP11alpha and CYP17 genes and the etiology of hyperandrogenism in patients with polycystic ovary syndrome. Medicina (B Aires) 68(2):129–134
Tan L, Zhu G (2005) Role of the pentanucleotide (tttta)n polymorphisms of Cyp11alpha gene in the pathogenesis of hyperandrogenism in Chinese women with polycystic ovary syndrome. J Huazhong Univ Sci Technol Med Sci 25(2):216–218
San Millán JL et al (2001) Role of the pentanucleotide (tttta) n polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism. Fertil Steril 75(4):797–802
Wang Y et al (2005) Microsatellite polymorphism of (tttta) n in the promoter of CYP11a gene in Chinese women with polycystic ovary syndrome. Natl Med J China 85(48): 3396–3400
Gao G et al. (2010) Polymorphism of CYP11A1 gene in Chinese patients with polycystic ovarian syndrome. China J Obstet Gynecol 45(3):191–196
Pusalkar M et al (2009) CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome. Fertil Steril 92(2):653–659
Hao CF et al (2009) Evaluation of association between the CYP11alpha promoter pentannucleotide (TTTTA)n polymorphism and polycystic ovarian syndrome among Han Chinese women. Neuro Endocrinol Lett 30(1):56–60
Gaasenbeek M et al (2004) Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab 89(5):2408–2413
Sterne J et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343(7818):302–307
Daneshmand S et al (2002) Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17alpha-hydroxylase/C(17-20) lyase promoters. Fertil Steril 77(2):274–280
Nelson VL et al (1999) Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13(6):946–957
Jakimiuk AJ et al (2001) Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 86(3):1318–1323
Lim SK et al (2002) Polymorphism of CYP17 and CYP11 alpha for polycystic ovary syndrome in a Korean population. Korean J Genet 24(4):343–348
Zhang C et al (2012) Association between polymorphisms of the CYP11A1 gene and polycystic ovary syndrome in Chinese women. Mol Biol Rep 39(8):8379–8385
Cui L et al (2013) Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum Reprod 28(2):538–544
Shi Y et al (2012) Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet 44(9):1020–1025
Dupont WD, Plummer WJ (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11(2):116–128
Acknowledgments
We would like to thank Dr. Stephen Franks, Dr. Zijiang Chen and Dr. Anurupa Maitra for answering our e-mails and giving valuable advice to our meta-analysis. This work was supported by grants from the National Basic Research Program of China (No. 2011CB504502), the National Natural Science Foundation of China (Grant No. 8100467 and No. 81270747), Innovation Program of Shanghai Municipal Education Commission (Grant No. 13ZZ001) and the Fundamental Research Fund for Central University.
Conflict of interest
The authors declare no conflicts of interest, financial or otherwise.
Author information
Authors and Affiliations
Corresponding author
Additional information
Min Yu and Ruizhi Feng contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yu, M., Feng, R., Sun, X. et al. Polymorphisms of pentanucleotide repeats (tttta)n in the promoter of CYP11A1 and their relationships to polycystic ovary syndrome (PCOS) risk: a meta-analysis. Mol Biol Rep 41, 4435–4445 (2014). https://doi.org/10.1007/s11033-014-3314-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-014-3314-3